🇺🇸 FDA
Patent

US 12016952

Methods of preparing a monodisperse oligo(ethylene glycol) reagent composition

granted A61KA61K31/167A61K31/485

Quick answer

US patent 12016952 (Methods of preparing a monodisperse oligo(ethylene glycol) reagent composition) held by Nektar Therapeutics expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/167, A61K31/485, A61K47/60, A61K9/007